Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis

European Annals of Allergy and Clinical Immunology

Volumn 47, Issue 6, 2015, Pages 192-196

  Verburg, M ^a   Oldhoff, J M ^a   Klemans, R J B ^a   Lahey De Boer, A ^a   De Bruin Weller, M S ^a   Rockmann H ^a   Sanders, C ^a   Bruijnzeel Koomen, C A F M ^a   Pasmans, S G M A ^a   Knulst, A C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Immunotherapy; Mastocytosis; Tryptase; Urticaria pigmentosa; Wasp venom allergy; Yellow jacket venom allergy

Indexed keywords

ADRENALIN; ALLPYRAL; ALUTARD; ANTIHISTAMINIC AGENT; CETIRIZINE; IMMUNOGLOBULIN E ANTIBODY; PREDNISOLONE; TRYPTASE; WASP VENOM;

ADULT; AGED; ARTICLE; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; ERYTHEMA; FEMALE; HEART PALPITATION; HISTOPATHOLOGY; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INDOLENT SYSTEMIC MASTOCYTOSIS; INSECT ALLERGY; MAINTENANCE THERAPY; MALE; MIDDLE AGED; TACHYCARDIA; THORAX PAIN; TREATMENT RESPONSE; URTICARIA PIGMENTOSA; VENOM IMMUNOTHERAPY; WASP STING; WASP VENOM ALLERGY; ADVERSE EFFECTS; ANIMAL; DESENSITIZATION; HYPERSENSITIVITY; IMMUNOLOGY; INSECT BITES AND STINGS; MASTOCYTOSIS, CUTANEOUS; MASTOCYTOSIS, SYSTEMIC; PROCEDURES; RECURRENT DISEASE; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; WASP;

ADULT; AGED; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY; INSECT BITES AND STINGS; MALE; MASTOCYTOSIS, CUTANEOUS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WASP VENOMS; WASPS;

EID: 84946837456     PISSN: 17641489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25(7):603-25.
2. Ruëff F, Placzek M, Przybilla B. Mastocytosis and Hymenoptera venom allergy. Curr Opin Allergy Clin Immunol. 2006;6(4):284-8.
3. Niedoszytko M, de MJ, van Doormaal JJ, Jassem E, Oude Elberink JN. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy. Allergy. 2009;64(9):1237-45.
4. Ruëff F, Przybilla B. [Venom immunotherapy. Side effects and efficacy of treatment]. Hautarzt. 2008;59(3):200-5.
5. Brockow K, Kiehn M, Riethmuller C, Vieluf D, Berger J, Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1997;100(4):458-63.
6. Muller UR, Horat W, Wuthrich B, Conroy M, Reisman RE. Anaphylaxis after Hymenoptera stings in three patients with urticaria pigmentosa. J Allergy Clin Immunol. 1983;72(6):685-9.
7. Oude Elberink JN, de Monchy JG, Kors JW, van Doormaal JJ, Dubois AE. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol. 1997;99(1 Pt 1):153-4.
8. Dubois AE. Mastocytosis and Hymenoptera allergy. Curr Opin Allergy Clin Immunol. 2004;4(4):291-5.
9. Bonadonna P, Zanotti R, Caruso B, Castellani L, Perbellini O, Colarossi S et al. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy. J Allergy Clin Immunol. 2008;121(1):256-7.
10. Fricker M, Helbling A, Schwartz L, Muller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol. 1997;100(1):11-5.
11. Gonzalez de OD, Alvarez-Twose I, Esteban-Lopez MI, Sanchez-Munoz L, de Durana MD, Vega A et al. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol. 2008; 121(2):519-26.
12. Muller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol. 1992;89(2):529-35.
13. Ruëff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W et al. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol. 2010;126(1):105-11.
14. Przybilla B, Ruëff F. Hymenoptera venom allergy. J Dtsch Dermatol Ges. 2010;8(2):114-27.